Impact of retransfusion of blood processed in cell-saver on coagulation versus cardiopulmonary bypass: A prospective observational study using thromboelastography
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10294909" target="_blank" >RIV/00216208:11130/15:10294909 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/15:10294909
Result on the web
<a href="http://dx.doi.org/10.5507/bp.2013.012" target="_blank" >http://dx.doi.org/10.5507/bp.2013.012</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2013.012" target="_blank" >10.5507/bp.2013.012</a>
Alternative languages
Result language
angličtina
Original language name
Impact of retransfusion of blood processed in cell-saver on coagulation versus cardiopulmonary bypass: A prospective observational study using thromboelastography
Original language description
Aims. To compare an impact of retransfusion of blood processed in cell-saver (CS) with that of cardiopulmonary bypass (CPB) on blood coagulation in patients undergoing cardiac surgery. Methods. Prospective observational study using thromboelastography (TEG). Results. TEG samples from 170 patients were analyzed. Cardiopulmonary bypass was used in 100 patients while 70 patients were operated off-pump. In 20 off-pump patients collected blood was processed by cell-saver and returned. In all patients clot formation after heparin neutralization by protamine was unimpaired. However, there was a significant increase in fibrinolysis defined by the TEG parameter Lysis time 30 min after the maximum amplitude of the clot was reached (Ly30) in groups with CPB or CSbut this increase still did not exceed the threshold for clinical fibrinolysis (Ly30 > 7.5%). In the group without CPB there was no significant impact on coagulation. Conclusion. Surgery that avoids CPB and/or CS is the gentlest method f
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Volume of the periodical
159
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
4
Pages from-to
131-134
UT code for WoS article
000351716500021
EID of the result in the Scopus database
2-s2.0-84924519854